Host: |
Mouse |
Applications: |
WB/ELISA |
Reactivity: |
Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-ASPSCR1 is suitable for use in Western Blot and ELISA research applications. |
Clonality: |
Monoclonal |
Clone ID: |
4A11A6G11 |
Conjugation: |
Unconjugated |
Isotype: |
IgG1 |
Formulation: |
Liquid in PBS containing 0.03% Sodium Azide. |
Purification: |
Affinity purification |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-1:2000ELISA 1:10000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Specificity: |
TUG Monoclonal Antibody detects endogenous levels of TUG protein. |
Immunogen: |
Purified recombinant fragment of TUG expressed in E. Coli. |
Function | Tethering protein that sequesters GLUT4-containing vesicles in the cytoplasm in the absence of insulin. Modulates the amount of GLUT4 that is available at the cell surface. Enhances VCP methylation catalyzed by VCPKMT. |
Protein Name | Tether Containing Ubx Domain For Glut4Alveolar Soft Part Sarcoma Chromosomal Region Candidate Gene 1 ProteinAlveolar Soft Part Sarcoma LocusRenal Papillary Cell Carcinoma Protein 17Ubx Domain-Containing Protein 9 |
Database Links | Reactome: R-HSA-1445148 |
Cellular Localisation | Endomembrane SystemPeripheral Membrane ProteinEndoplasmic Reticulum-Golgi Intermediate Compartment MembraneCytoplasmNucleus |
Alternative Antibody Names | Anti-Tether Containing Ubx Domain For Glut4 antibodyAnti-Alveolar Soft Part Sarcoma Chromosomal Region Candidate Gene 1 Protein antibodyAnti-Alveolar Soft Part Sarcoma Locus antibodyAnti-Renal Papillary Cell Carcinoma Protein 17 antibodyAnti-Ubx Domain-Containing Protein 9 antibodyAnti-ASPSCR1 antibodyAnti-ASPL antibodyAnti-RCC17 antibodyAnti-TUG antibodyAnti-UBXD9 antibodyAnti-UBXN9 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance